A Study Comparing The Switching Effect Of Daily Teriparatide (TPTD) To Oral Bisphosphonates (BP) And Denosumab (DMAb) In Patients With Primary Osteoporosis.

Trial Profile

A Study Comparing The Switching Effect Of Daily Teriparatide (TPTD) To Oral Bisphosphonates (BP) And Denosumab (DMAb) In Patients With Primary Osteoporosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2017

At a glance

  • Drugs Denosumab (Primary) ; Alendronic acid; Minodronic acid; Risedronic acid
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top